US Broker Ratings

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unpacking the 34% Potential Upside in the Medical Device Sector

Investors with an eye on the healthcare sector, particularly the medical device industry, may find Establishment Labs Holdings Inc (NASDAQ: ESTA) a compelling prospect. Headquartered in Alajuela, Costa Rica, this..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Through Healthcare with a 8.06% Potential Upside

Azenta, Inc. (NASDAQ: AZTA) offers a compelling story for investors in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.4 billion and..

NeoGenomics, Inc. (NEO) Stock Analysis: Decoding a 11.36% Potential Upside in the Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO), a key player in the diagnostics and research industry, presents a compelling opportunity for investors looking to tap into the healthcare sector. With a market capitalization..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Eyeing a 108.92% Potential Upside in Biotech

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a promising player in the biotechnology sector, offers investors an intriguing opportunity with a potential upside of 108.92%, according to analysts’ average target price. Specializing..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Investor Outlook and Growth Potential in the Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is capturing the attention of investors with its innovative approach to healthcare, particularly in the burgeoning field of biotechnology. With a market capitalization of $2.01..

Aveanna Healthcare Holdings Inc (AVAH) Investor Outlook: Navigating Growth in Home Care with a 16.8% Revenue Surge

Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the healthcare sector, offers a compelling narrative for investors focused on the medical care facilities industry. Headquartered in Atlanta, Georgia, Aveanna..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: A Promising 26.4% Upside Potential in the Biotech Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), with its headquarters in Cambridge, Massachusetts, is a notable player in the biotechnology segment of the healthcare sector. The company is primarily focused on the..

Phreesia, Inc. (PHR) Stock Analysis: Navigating 45.7% Revenue Growth in the Health Information Services Sector

Phreesia, Inc. (NYSE: PHR) stands as a notable player in the healthcare sector, particularly within the health information services industry. Known for its integrated SaaS-based software and payment platform, Phreesia..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 278.64% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its innovative approach to developing oral small molecule therapeutics aimed at addressing chronic diseases..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating Its 6.38% Return on Equity and Market Prospects

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is making waves in the healthcare sector, focusing on the development and commercialization of treatments for central nervous system (CNS) diseases. With a market capitalization..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a 6.68% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands as a notable player in the healthcare sector, carving its niche within the drug manufacturing industry focusing on specialty and generic pharmaceuticals. With a..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring the 8.74% Upside Potential Amidst Innovative Non-Opioid Solutions

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a compelling player in the healthcare sector, specializing in non-opioid pain management and regenerative health solutions. With a market capitalization of $1.2 billion, this..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 92% Potential Upside Awaits Investors

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine oncology, offering intriguing potential for investors seeking high-growth opportunities in the biotechnology sector. With a market capitalization of..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A Healthcare Gem with Robust Revenue Growth and Promising Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a prominent player in the medical instruments and supplies industry, and its recent financial performance underscores its potential as a compelling investment opportunity. With..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a 101% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a pioneering entity in the healthcare sector, has become a focal point of interest for investors seeking exposure to the specialty and generic drug manufacturing..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Potential 41.81% Upside Ignites Investor Interest

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology firm specializing in neuroscience, has become a focal point for investors seeking significant growth potential. With its current stock price at $38.71..

Healthcare Services Group, Inc. (HCSG): Investor Outlook and Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a pivotal player in the healthcare sector, offers vital management, administrative, and operational services across the United States. With a focus on housekeeping and..

Evotec SE (EVO): Exploring a 70% Upside Potential in the Drug Discovery Sector

Investors seeking opportunities in the healthcare sector may want to consider Evotec SE (EVO), a leading player in the drug discovery and development industry. With a market capitalization of $1.24..

National HealthCare Corporation (NHC) Stock Analysis: A Stable Healthcare Investment with Robust Revenue Growth

National HealthCare Corporation (NYSE: NHC) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Based in Murfreesboro, Tennessee, NHC operates a diverse range of..

Indivior PLC (INDV) Stock Analysis: Exploring 20% Upside Potential for Investors

Indivior PLC (INDV), a key player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing, has recently caught the attention of investors due to its..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds